Skip to content

To study the efficacy of strontium ranelate on the healing of surgically fixed diaphyseal tibial fractures and compare it to placebo

Efficacy of Strontium Ranelate versus placebo on time to fracture healing of tibial fractures in adults

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611000876998
Enrollment
100
Registered
2011-08-17
Start date
2011-08-15
Completion date
2012-04-24
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Strontium Ranelate is approved for treatment of osteoporosis. Its mode of action is thought to be a combination of anti resorptive and anabolic on bone. The bone forming ability has been documented in animal studies as well as in the increase in level of P1NP (A bone formation marker). There are anecdotal reports that it enhances fracture healing in humans but very little prospective data is present. The purpose of this study is to study the efficacy of strontium ranelate in the dose of 2gm daily on the healing of surgically fixed diaphyseal tibial fractures and compare it to placebo.

Interventions

The purpose of this study is to study the efficacy of strontium ranelate in the dose of 2gm daily on the healing of surgically fixed diaphyseal tibial fractures and compare it to placebo. The subjects will receive strontium ranelate for a period of 3months commencing from the 1st day after fracture fixation. Strontium ranelate will be administered in an oral suspension form with yellow granules in a sachet to be mixed in 30ml water.

Sponsors

Pharmevo (Pvt.) Ltd.
Lead SponsorCommercial sector/Industry

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

All adult patients between 18 and 60 years of age presenting with closed diaphysial tibial fractures, amenable to fixation with a Dynamic Compression Plate / Locking Compression Plate

Exclusion criteria

All open fractures Patients under 18 yrs or over 60 yrs Metaphyseal /periarticular fractures Patients with previous procedures in that limb Fractures requiring bone grafting Pregnant patients Patients with renal impairment

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026